Literature DB >> 16044737

Completion thyroidectomy after the unexpected diagnosis of thyroid cancer.

B Dewil1, B Van Damme, V Vander Poorten, P Delaere, F Debruyne.   

Abstract

The optimal surgical management of well-differentiated thyroid cancer (DTC) remains a controversial topic. Preoperative and peroperative investigations quite frequently fail to detect thyroid cancer in cold nodules, and only postoperative histological examination reveals malignancy. In these cases many physicians perform a completion thyroidectomy. Others recommend a conservative approach with close follow-up because of the increased risk of complications after re-operation. In our department, routine management includes completion thyroidectomy once the histopathological report concludes that there is carcinoma, except in cases of papillary carcinoma measuring less than 1 cm. The aim of our study was to determine the incidence of contralateral malignancy and of complications after completion thyroidectomy. We reviewed the records of 29 patients--25 women and 4 men-- who all underwent completion thyroidectomy because of an unexpected diagnosis of DTC. Residual malignancy was found in 12 patients (41.4%) after completion thyroidectomy. In ten patients (34.5%) the malignancy was localised in the contralateral lobe and two patients (6.9%) had lymph node metastases. Postoperative transient hypocalcaemia (< 8.0 mg/dl) occurred in five patients (17.2%) and permanent hypocalcaemia (lasting longer than 6 months) was a feature in two patients. One patient suffered transient laryngeal nerve injury occurred in one patient and there were no permanent lesions. In conclusion, we found residual DTC in 41.4% of patients undergoing reintervention. Because of the rather low re-operation rate, we prefer to perform a completion thyroidectomy to remove potential occult malignancy and to allow for postoperative 131I-treatment in all patients with a diagnosis of malignancy in their thyroid lobectomy specimen, with the exception of papillary carcinoma < 1 cm.

Entities:  

Mesh:

Year:  2005        PMID: 16044737

Source DB:  PubMed          Journal:  B-ENT        ISSN: 1781-782X            Impact factor:   0.082


  5 in total

1.  Completion thyroidectomy in differentiated thyroid cancer: When to perform?

Authors:  Abdullah Kısaoğlu; Bünyami Özoğul; Müfide Nuran Akçay; Gürkan Öztürk; Sabri Selçuk Atamanalp; Bülent Aydınlı; Salih Kara
Journal:  Ulus Cerrahi Derg       Date:  2014-03-01

2.  Completion thyroidectomy: effect of timing on clinical complications and oncologic outcome in patients with differentiated thyroid cancer.

Authors:  Gabriel Glockzin; Matthias Hornung; Klaus Kienle; Katrin Thelen; Marita Boin; Andreas G Schreyer; Hamid R Lighvani; Hans J Schlitt; Ayman Agha
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

3.  Role of Scrape Cytology as an Adjunct to Fine Needle Aspiration Cytology in Diagnosis of Thyroid Lesions.

Authors:  Mehnaaz Sultan Khuroo; Shaista Mushtaq; Summyia Farooq; Ambreen Beigh; Naila Nazir; Ruby Reshi
Journal:  J Clin Diagn Res       Date:  2016-10-01

4.  Can shear wave elastography determine remnant thyroid tissue in the early postoperative period in patients with differentiated thyroid carcinoma?

Authors:  Emine Uysal; Gonca Kara Gedik; Mehmet Sedat Durmaz; Farise Yılmaz; Abdussamed Batur
Journal:  J Ultrasound       Date:  2021-04-05

5.  Thyroid Remnant Estimation by Diagnostic Dose (131)I Scintigraphy or (99m)TcO4(-) Scintigraphy after Thyroidectomy: A Comparison with Therapeutic Dose (131)I Imaging.

Authors:  Guanghui Liu; Na Li; Xuena Li; Song Chen; Bulin Du; Yaming Li
Journal:  Biomed Res Int       Date:  2016-01-21       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.